Paris Atos, a global leader in digital transformation, was selected by GCS AURAGEN[1] – to provide and orchestrate the high-performance computing infrastructure and storage of a new genomic pilot platform for high-flow sequencing calculation. This platform has been selected as part of the French national plan for Genomic Science (‘France Médecine Génomique 2025’[2]). Atos will manage […]

PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that the entire staff from Compass Strategic Consulting (Compass) has joined Certara’s Evidence & Access group.  Certara Evidence & Access was formed through the acquisition of Analytica Laser (market access, health economics and real-world […]

PRINCETON, NJ –  Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that it has formed a new practice area called Certara Global Health (CGH) to focus its technological expertise on helping to achieve equity in health for all people worldwide. CGH is a new product […]

Genedata E2E software solution to increase speed and efficiency of discovery and development of Genmab’s next-generation cancer therapies Basel, Switzerland ‒ Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced that Genmab, an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer, […]

DRVISION wins up to 3.27 million USD NIMH SBIR grant to develop the Intelligent Connectomics Analysis platform within Aivia BELLEVUE, WA, UNITED STATES — DRVISION Technologies, a pioneer in computer vision and the world’s leading AI microscopy software company has been awarded up to 3.27 million USD from the National Institute of Mental Health (NIMH) to […]

Acquisition strengthens Bruker’s portfolio of high-performance PET molecular imaging solutions ZURICH, Switzerland — Bruker today announced that it has acquired PMOD Technologies LLC, a highly respected provider of research-use-only software for preclinical and molecular imaging, with a focus on molecular quantification and pharmacokinetic modeling. The PMOD software is widely used for the analysis of positron […]

Tokyo, Japan – Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) announced that Hitachi High Technologies America, Inc. (CEO: Craig Kerkove), a subsidiary of Hitachi High-Tech, will team with SparkCognition, Inc. (CEO: Amir Husain, “SparkCognition”) to deploy SparkCognition’s proprietary automated machine learning modeling platform, Darwin, at Hitachi High-Tech Group’s customers in Japan and other areas in […]

Genedata Selector® positioned as data management platform to increase the efficiency of the discovery process for innovative enzymes Basel, Switzerland Genedata, a leading provider of advanced software solutions for life science R&D, today announced that it has expanded its partnership with AB Enzymes, a member of Associated British Foods and one of the world’s leading enzyme […]

We are happy to announce the Summer ’19 Release of the Human Gene Mutation Database (HGMD) Professional is now available to customers globally. The Summer ’19 release contains over 260,000 expert-curated, disease-causing mutations, providing clinical researchers with an ever-expanding gamut of knowledge and tools to improve their gene and mutation-level data analysis.   Release highlights […]

Genedata Imagence® automates high-content screening workflows Basel, Switzerland – Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced a collaboration with AstraZeneca to automate high-content screening (HCS) image analysis using Genedata Imagence®. Genedata Imagence is the industry’s first commercial, HCS instrument-independent solution that applies the deep-learning approach to automate the analysis of […]